lity" (1). With this exchange of genetic material, we may never have to worry about crops falling victim to certain threatening diseases and we may someday produce twice the yield from half the land. Pharmaceuticals invest in biotechnology, in an attempt to seek out lower-cost health care. When calculating health care costs, many people look at pharmaceutical companies as a group of aristocrats set out to take everyone's money. Richard J. Mahoney, in a speech given to the Executive Club of Chicago, explains how pharmaceuticals are not to blame for high-cost health care:
             In an attempt to combat health care costs, some have moved in on pharmaceuticals. The attempt to control health care costs is indeed noble one-but pharmaceuticals are the wrong target. They represent only 6 percent of total health care costs and they're probably the most cost-effective part of the equation. Ask any ulcer victim who has traded a $15,000, not-very-effective surgical procedure for $1,000 a year of Tagamet or Zantac to relieve the ulcers. In fact, if you took all the pr
             ...